Status:
UNKNOWN
Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma
Lead Sponsor:
Sun Yat-sen University
Conditions:
Diffuse Large B Cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the predictive value of a mRNA signature and liquid biopsy in patients with Diffuse Large B cell lymphoma.
Eligibility Criteria
Inclusion
- biopsy proved Diffuse Large B cell Lymphoma
- newly diagnosed between 2000-01 and 2015-12
Exclusion
- patients with biopsy samples unavailable
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04423549
Start Date
June 1 2020
End Date
June 1 2021
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University,
Guangzhou, China, 51000